Undertreatment of people with major depressive disorder in 21 countries

Imagem de Miniatura
Arquivos
art_THORNICROFT_Undertreatment_of_people_with_major_depressive_disorder_in_2017.PDF (379.55 KB)
Citações na Scopus
604
Tipo de produção
article
Data de publicação
2017
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ROYAL COLLEGE OF PSYCHIATRISTS
Autores
THORNICROFT, Graham
CHATTERJI, Somnath
EVANS-LACKO, Sara
GRUBER, Michael
SAMPSON, Nancy
AGUILAR-GAXIOLA, Sergio
AL-HAMZAWI, Ali
ALONSO, Jordi
BORGES, Guilherme
Citação
BRITISH JOURNAL OF PSYCHIATRY, v.210, n.2, p.119-124, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background Major depressive disorder (MDD) is a leading cause of disability worldwide. Aims To examine the: (a) 12-month prevalence of DSM-IV MDD; (b) proportion aware that they have a problem needing treatment and who want care; (c) proportion of the latter receiving treatment; and (d) proportion of such treatment meeting minimal standards. Method Representative community household surveys from 21 countries as part of the World Health Organization World Mental Health Surveys. Results Of 51 547 respondents, 4.6% met 12-month criteria for DSM-IV MDD and of these 56.7% reported needing treatment. Among those who recognised their need for treatment, most (71.1%) made at least one visit to a service provider. Among those who received treatment, only 41.0% received treatment that met minimal standards. This resulted in only 16.5% of all individuals with 12-month MDD receiving minimally adequate treatment. Conclusions Only a minority of participants with MDD received minimally adequate treatment: 1 in 5 people in high-income and 1 in 27 in low-/lower-middle-income countries. Scaling up care for MDD requires fundamental transformations in community education and outreach, supply of treatment and quality of services.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/19124
Referências
  1. Agency for Health Care Policy and Research, 1993, DEPR GUID PAN, V2
  2. American Psychiatric Association, 1994, DIAGN STAT MAN MENT
  3. American Psychiatric Association, 2006, PRACT GUID TREATM PS
  4. Andrade LH, 2014, PSYCHOL MED, V44, P1303, DOI 10.1017/S0033291713001943
  5. Barbui C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000322
  6. Bernert S, 2009, PSYCHIAT RES, V168, P137, DOI 10.1016/j.psychres.2008.04.008
  7. Birnbaum HG, 2010, DEPRESS ANXIETY, V27, P78, DOI 10.1002/da.20580
  8. Chisholm D, 2003, BRIT J PSYCHIAT, V183, P121, DOI 10.1192/bjp.183.2.121
  9. Clement S, 2015, PSYCHOL MED, V45, P11, DOI 10.1017/S0033291714000129
  10. Da Silva M, 2014, GLOBAL MENTAL HLTH T
  11. Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581
  12. Dua T, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001122
  13. Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X
  14. Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547
  15. First M, 2002, STRUCTURED CLIN INTE
  16. Gureje O, 2015, LANCET PSYCHIAT, V2, P12, DOI 10.1016/S2215-0366(14)00094-7
  17. Harkness J., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P91
  18. Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196
  19. Heeringa S. G., 2008, The WHO world mental health surveys: global perspectives on the epidemiology of mental disorders, P14
  20. Kessler RC, 2015, EPIDEMIOL PSYCH SCI, V24, P210, DOI 10.1017/S2045796015000189
  21. Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168
  22. Kessler RC, 2012, PSYCHIAT CLIN N AM, V35, P1, DOI 10.1016/j.psc.2011.11.005
  23. Krauth C, 2014, DEPRESS RES TREAT, V2014
  24. Lasalvia A, 2013, LANCET, V381, P55, DOI 10.1016/S0140-6736(12)61379-8
  25. Lehman AF, 1998, SCHIZOPHRENIA BULL, V24, P1
  26. Li Y, 2014, PSYCHOL MED, V44, P3275, DOI 10.1017/S0033291714000749
  27. Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12
  28. Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9
  29. Schrier AC, 2010, SOC PSYCH PSYCH EPID, V45, P941, DOI 10.1007/s00127-009-0135-0
  30. Simon GE, 2002, PSYCHOL MED, V32, P585, DOI 10.1017/S0033291702005457
  31. Thornicroft G, 2016, LANCET PSYCHIAT, V3, P599, DOI 10.1016/S2215-0366(16)30079-7
  32. United Nations, 2015, 2030 AG GLOB ACT SUS
  33. van Loo HM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-156
  34. Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
  35. Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7
  36. Wells JE, 2013, BRIT J PSYCHIAT, V202, P42, DOI 10.1192/bjp.bp.112.113134
  37. World Health Organization, 2013, GLOB MENT HLTH ACT P
  38. World Health Organization, 2010, MHGAP INT GUID MENT
  39. World Health Organization, 2014, PREV SUIC GLOB IMP
  40. *WORLD BANK, 2009, WORLD BANK REP MALN, DOI 10.1596/978-0-8213-7679-9

Coleções
Artigos e Materiais de Revistas Científicas - HC/IPq
Artigos e Materiais de Revistas Científicas - LIM/23